| Literature DB >> 34840581 |
Ruo-Yang Li1,2, Rui-Jue Huang3, Qian Yu1,2.
Abstract
OBJECTIVE: Physical therapy combined with acupuncture is the current research hotspot in the treatment of poststroke cognitive impairment, but which combination treatment is the best is still controversial. Based on the network meta-analysis method, we evaluated the efficacy of various physical therapies combined with acupuncture for the treatment of poststroke cognitive impairment.Entities:
Year: 2021 PMID: 34840581 PMCID: PMC8616672 DOI: 10.1155/2021/1101101
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1(a) Flow chart of literature screening. (b) Risk of bias graph.
Basic characteristics of the included trials.
| Author | Year | Number of patients | Age (year) | Male/female | Treatment | Intervention period (wk) | Outcome indicator | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | C | C2 | I | C | C2 | I | C | C2 | |||||
| Jiang [ | 2016 | 52 | 49 | 52 | 57.88 ± 9.45 | 56.18 ± 11.86 | 57.75 ± 13.74 | 72/81 | Acupuncture + RehaCom | Conventional treatment | Acupuncture | 12 | ①, ② |
| Deng [ | 2015 | 21 | 21 | — | 62.24 ± 10.25 | 25/17 | Acupuncture + TMS | Conventional treatment | — | 4 | ①, ②, ③ | ||
| Gao [ | 2019 | 30 | 30 | — | 64.33 ± 9.07 | 58.43 ± 14.02 | — | 36/24 | Acupuncture + TMS | Acupuncture | — | 3.7 | ①, ④ |
| Liang [ | 2010 | 59 | 55 | — | 61.2 ± 10.1 | 59.2 ± 11.2 | — | 68/46 | Acupuncture + HBO | Conventional treatment | — | 3.6 | ③, ④ |
| Liu [ | 2019 | 42 | 41 | — | 67.6 ± 6.48 | 68.3 ± 6.75 | — | 45/38 | Acupuncture + UWE | Acupuncture | — | 4 | ①、③ |
| Ma [ | 2018 | 30 | 30 | 30 | 60.97 ± 7.15 | 62.32 ± 8.84 | 60.12 ± 6.56 | 53/37 | Acupuncture + HBO | Acupuncture | HBO | 4.3 | ① |
| Wang [ | 2016 | 43 | 43 | — | 44.55 ± 30.23 | 44.45 ± 30.91 | — | 59/27 | Acupuncture + HBO | HBO | — | 2.9 | ④ |
| Xie [ | 2018 | 45 | 45 | — | 63.76 ± 6.84 | 64.23 ± 6.57 | — | 50/40 | Acupuncture + UWE | Acupuncture | — | 4 | ①, ③, ④ |
| Yang [ | 2020 | 29 | 29 | 28 | 58.41 ± 8.99 | 56.55 ± 8.53 | 60.11 ± 10.05 | 62/24 | Acupuncture + HBO | Acupuncture | HBO | 4 | ②, ③ |
| Yu [ | 2018 | 30 | 30 | — | 63.84 ± 1.55 | 34/26 | Acupuncture + TMS | Conventional treatment | — | 2.9 | ②, ③ | ||
| Zhang [ | 2012 | 60 | 55 | — | 59.2 ± 8.6 | 60.2 ± 9.2 | — | 69/46 | Acupuncture + HBO | Conventional treatment | — | 2.9 | ②, ③ |
| Zhang [ | 2013 | 34 | 34 | — | 64.70 ± 8.2 | 63.10 ± 7.6 | — | 44/24 | Acupuncture + HBO | Conventional treatment | — | 2.1 | ① |
| Zhang [ | 2016 | 43 | 43 | — | 67.3 ± 5.8 | 68.2 ± 5.5 | — | 52/34 | Acupuncture + HBO | HBO | — | 3 | ①, ④ |
| Jiang [ | 2015 | 28 | 28 | 27 | 55.13 ± 7.0 | 58.20 ± 6.82 | 56.73 ± 7.648 | 42/39 | Acupuncture + RehaCom | Conventional treatment | Acupuncture | 12 | ② |
| Bie [ | 2011 | 36 | 36 | — | 61.4 ± 9.8 | 62.1 ± 10.2 | — | 38/34 | Acupuncture + TMS | Acupuncture | — | 4 | ①, ④ |
① MMSE; ② MoCA; ③ BI; ④ the total effective rate of clinical treatment; I: Intervention; C: Control
Figure 2(a) Network diagram (Aa: MMSE; Ab: MoCA; Ac: BI; Ad: total effective rate). (b) Inconsistency (Ba: MMSE; Bb: MoCA).
Figure 3Network meta-analysis: (a) MMSE; (b) MoCA; (c) BI; and (d) the total effective rate.
Figure 4(a) Cumulative probability ranking plot (Aa: MMSE; Ab: MoCA; Ac: BI; Ad: total effective rate). (b) Funnel diagram of MMSE (A: conventional treatment; B: acupuncture; C: HBO; D: acupuncture + TMS; E: acupuncture + HBO; F: acupuncture + UWE; G: acupuncture + RehaCom).
Effect quantity and evidence classification of MMSE.
| Comparative measures | Direct comparison | Indirect comparison | Network meta-analysis | |||
|---|---|---|---|---|---|---|
| MD (95% CI) | Quality of evidence | MD (95% CI) | Quality of evidence | MD (95% CI) | Quality of evidence | |
| A VS C | 1.47 (0.92, 2.02) | Moderate% | Not evaluated$ | Not evaluated$ | 1.47 (0.99, 1.95) | Moderate |
| H VS C | — | — | 2.67 (1.13, 4.21) | Very low&#! | 2.67 (1.13, 4.21) | Very low |
| AT VS C | 3.05 (−0.43, 6.53) | Very low&%! | 2.52 (1.65, 3.38) | Very low##! | 2.55 (1.71, 3.39) | Very low |
| AH VS C | 5.45 (1.93, 8.97) | Very low&%! | 6.10 (4.41, 7.79) | Very low#∗! | 5.98 (4.46, 7.50) | Very low |
| AU VS C | — | — | 5.82 (4.36, 7.28) | Low#% | 5.82 (4.36, 7.28) | Low |
| AR VS C | 3.62 (3.14, 4.10) | Low%! | Not evaluated$ | Not evaluated$ | 3.62 (3.22, 4.02) | Low |
| H VS A | 1.11 (−0.47, 2.69) | Low&! | 1.80 (−2.31, 5.91) | Low&! | 1.20 (−0.28, 2.68) | Low |
| AT VS A | 1.06 (0.34, 1.78) | Moderate! | 1.59 (−1.92, 5.10) | Very low&#! | 1.08 (0.38, 1.78) | Moderate |
| AH VS A | 4.81 (3.11, 6.51) | Very low&%! | 3.60 (0.60, 6.60) | Very low&∗! | 4.51 (3.04, 5.98) | Very low |
| AU VS A | 4.35 (2.97, 5.73) | Moderate! | Not evaluated$ | Not evaluated$ | 4.35 (2.97, 5.73) | Moderate |
| AR VS A | 2.15 (1.60, 2.70) | Low%! | Not evaluated$ | Not evaluated$ | 2.15 (1.67, 2.63) | Low |
| AT VS H | — | — | −0.12 (−1.76, 1.52) | Very low&#! | −0.12 (−1.76, 1.52) | Very low |
| AH VS H | 3.36 (1.96, 4.76) | Moderate% | Not evaluated$ | Not evaluated$ | 3.31 (1.94, 4.68) | Moderate |
| AU VS H | — | — | 3.15 (1.13, 5.17) | Very low&#! | 3.15 (1.13, 5.17) | Very low |
| AR VS H | — | — | 0.95 (−0.59, 2.50) | Very low&#! | 0.95 (−0.59, 2.50) | Very low |
| AH VS AT | — | — | 3.43 (1.80, 5.06) | Low&! | 3.43 (1.80, 5.06) | Low |
| AU VS AT | — | — | 3.27 (1.72, 4.82) | Very low&!∗ | 3.27 (1.72, 4.82) | Very low |
| AR VS AT | — | — | 1.07 (0.23, 1.92) | Very low&!∗ | 1.07 (0.23, 1.92) | Very low |
| AU VS AH | — | — | −0.16 (−2.17, 1.86) | Very low&!% | −0.16 (−2.17, 1.86) | Very low |
| AR VS AH | — | — | −2.36 (−3.89, −0.83) | Very low&!% | −2.36 (−3.89, −0.83) | Very low |
| AR VS AU | — | — | −2.20 (−3.66, −0.74) | Very low&%! | −2.20 (−3.66, −0.74) | Very low |
&, study limitations; #, indirectness; ∗, inconsistency; %, imprecision; !, publication bias; $, not evaluated, because the treatment protocol is not in the evidence network: indirectness due to nontransitivity or indirectness between the mesh meta-analysis population and the included trial population.